Goldman Sachs’s ProKidney PROK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $344K | Buy |
580,823
+362,854
| +166% | +$215K | ﹤0.01% | 4455 |
|
|
2025
Q1 | $191K | Sell |
217,969
-74,027
| -25% | -$64.9K | ﹤0.01% | 4691 |
|
|
2024
Q4 | $493K | Buy |
291,996
+103,907
| +55% | +$176K | ﹤0.01% | 4305 |
|
|
2024
Q3 | $361K | Buy |
188,089
+143,072
| +318% | +$275K | ﹤0.01% | 4265 |
|
|
2024
Q2 | $111K | Sell |
45,017
-4,247
| -9% | -$10.4K | ﹤0.01% | 4487 |
|
|
2024
Q1 | $80.8K | Buy |
49,264
+11,631
| +31% | +$19.1K | ﹤0.01% | 4487 |
|
|
2023
Q4 | $67K | Sell |
37,633
-12,602
| -25% | -$22.4K | ﹤0.01% | 4517 |
|
|
2023
Q3 | $230K | Sell |
50,235
-35,721
| -42% | -$164K | ﹤0.01% | 4204 |
|
|
2023
Q2 | $962K | Buy |
85,956
+67,314
| +361% | +$753K | ﹤0.01% | 3628 |
|
|
2023
Q1 | $211K | Buy |
18,642
+2,920
| +19% | +$33.1K | ﹤0.01% | 4499 |
|
|
2022
Q4 | $108K | Buy |
+15,722
| New | +$108K | ﹤0.01% | 4658 |
|
|
2022
Q3 | – | Sell |
-43,400
| Closed | -$432K | – | 5618 |
|
|
2022
Q2 | $432K | Buy |
+43,400
| New | +$432K | ﹤0.01% | 4472 |
|